Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Fredun Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:539730 P/E (TTM) :33.02
ISIN Demat:INE194R01017 Div & Yield %:0.04 EPS (TTM) :49.65
Book Value (RS) :299.4743419 Market Cap (Rs Cr.):773.97 Face Value (RS) :10
    Change Company 
YearsMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Debt-Equity Ratio0.880.850.830.880.67
Long Term Debt-Equity Ratio0.130.350.640.480.28
Current Ratio1.501.691.731.371.29
Fixed Assets6.085.865.603.593.14
Inventory2.142.793.942.272.47
Debtors7.004.403.423.353.97
Interest Cover Ratio2.572.892.811.731.56
PBIDTM (%)11.1710.786.917.167.85
PBITM (%)10.089.755.945.666.18
PBDTM (%)7.257.404.793.893.88
CPM (%)5.584.963.792.993.35
APATM (%)4.493.942.821.501.68
ROCE (%)16.9517.4312.909.3410.16
RONW (%)14.3413.1511.414.764.73

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)